Marla Persky

Marla Persky, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cytyc Corp and Xeris Biopharma Holdings, Inc. We count 22 filings; the first trade dates from 19 July 2005 and the latest from 11 September 2025.

In open-market terms, that means 1 purchase worth €9,398 on one side and 3 sales worth €3.5M on the other. The net balance comes to €3.5M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 11 option exercises. Since January 2025: no purchases and 1 sale on the market.

The latest filing, published on 12 September 2025, reports an open-market sale of €102k in Xeris Biopharma Holdings, Inc. The latest purchase dates back some time: it was published 1,090 days ago, on 15 November 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.